Advertisement
Home 2018

Yearly Archives: 2018

For patients with hereditary angioedema type I or II

Lanadelumab Reduces Attack Rate in Hereditary Angioedema

0
Significant reduction in attack rate compared with placebo seen for three dose regimens of lanadelumab
Feature tagging of home videos for machine learning classification of autism spectrum disorder with the use of a mobile device produces accurate results in short time frames

Feature Tagging of Home Videos Promising in Autism Diagnosis

0
On mobile platform, highest accuracy seen with sparse five-feature logistic regression classifier
Higher consumption of vegetables and fruits is associated with lower odds of future memory loss in men

Fruits, Veggies, Orange Juice May Protect Men’s Memory

0
Findings based on subsequent memory loss 20 years after food assessment
Women with one of three breast cancer risk factors may benefit from mammography screening beginning at age 30

RSNA: Mammography May Benefit 30-Year-Olds With Risk Factors

0
Early screening may benefit those with dense breasts, personal/family history of breast cancer
Large for gestational age is a stronger marker than maternal diabetes for subsequently being overweight or obese in early childhood

Large at Birth, Maternal Diabetes Up Child’s Risk for Obesity

0
Breastfeeding lowers risk in those large for gestational age, but only without maternal diabetes
Children with amblyopia report lower self-perception for scholastic

Amblyopia Linked to Lower Self-Perception in Children

0
Lower perception of scholastic, social, athletic competence could affect reading, motor skills
A home-based intervention can improve disadvantaged chronic kidney disease patients' activation in their health and health care

Home-Based Intervention Helpful for Disadvantaged CKD Patients

0
Rural Zuni Indians with kidney disease had improved activation in their own health and health care
For very old adults

Protein Intake Tied to Disability Trajectory in Very Old

0
Intake of at least 1 g/kg of adjusted body weight per day linked to better disability trajectories
Vitrakvi (larotrectinib) has been approved by the U.S. Food and Drug Administration to treat adult and pediatric patients whose cancers have a specific genetic feature.

FDA Approves Vitrakvi for Cancers With Certain Genetic Trait

0
Drug targets solid tumors with NTRK gene fusion without a known acquired resistance mutation
The U.S. Food and Drug Administration is warning men that "Rhino" products promising better sex may pose serious health risks.

Men Should Avoid ‘Rhino’ Sexual Enhancement Products, FDA Says

0
Reports include chest pain, severe headaches, prolonged erections after taking Rhino products